Protective immunity against mouse upper genital tract pathology correlates with high IFNγ but low IL-17 T cell and anti-secretion protein antibody responses induced by replicating chlamydial organisms in the airway

Vaccine

Volumn 30, Issue 2, 2012, Pages 475-485

  Lu, Chunxue ^a,b   Zeng, Hao ^a   Li, Zhihong ^a   Lei, Lei ^a   Yeh, I Tien ^a   Wu, Yimou ^b   Zhong, Guangming ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF SOUTH CHINA   (China)

Author keywords

Chlamydia muridarum; IFN and IL 17; Live infection; Pathology; Secretion proteins

Indexed keywords

CHLAMYDIA MURIDARUM VACCINE; GAMMA INTERFERON; INACTIVATED VACCINE; INTERLEUKIN 17; INTERLEUKIN 5; LIVE VACCINE; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL SECRETION SYSTEM; BACTERIAL SHEDDING; CHLAMYDIA; CHLAMYDIASIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; UROGENITAL TRACT INFECTION;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL SHEDDING; BACTERIAL VACCINES; CHLAMYDIA INFECTIONS; CHLAMYDIA MURIDARUM; FEMALE; INTERFERON-GAMMA; INTERLEUKIN-17; MICE; REPRODUCTIVE TRACT INFECTIONS; T-LYMPHOCYTES; VACCINES, ATTENUATED; VACCINES, INACTIVATED; VAGINA;

EID: 84355161489     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.10.059     Document Type: Article

References (79)

1. Centers for Disease Control and Prevention C. Sexually Transmitted Disease Surveillance, 2008. In: Services USDoHaH, editor. Atlanta, GA: , 2009. http://www.cdc.gov/std/stats08/toc.htm.
2. Rockey D.D., Wang J., Lei L., Zhong G. Chlamydia vaccine candidates and tools for chlamydial antigen discovery. Expert Rev Vaccines 2009, 8(October (10)):1365-1377.
3. Sherman K.J., Daling J.R., Stergachis A., Weiss N.S., Foy H.M., Wang S.P., et al. Sexually transmitted diseases and tubal pregnancy. Sex Transm Dis 1990, 17(July-September (3)):115-121.
4. Kinnunen A.H., Surcel H.M., Lehtinen M., Karhukorpi J., Tiitinen A., Halttunen M., et al. HLA DQ alleles and interleukin-10 polymorphism associated with Chlamydia trachomatis-related tubal factor infertility: a case-control study. Hum Reprod 2002, 17(August (8)):2073-2078.
5. Stephens R.S. The cellular paradigm of chlamydial pathogenesis. Trends Microbiol 2003, 11(January (1)):44-51.
6. Zhong G. Killing me softly: chlamydial use of proteolysis for evading host defenses. Trends Microbiol 2009, 17(October (10)):467-474.
7. Rockey D.D., Scidmore M.A., Bannantine J.P., Brown W.J. Proteins in the chlamydial inclusion membrane. Microbes Infect 2002, 4(March (3)):333-340.
8. Li Z., Chen C., Chen D., Wu Y., Zhong Y., Zhong G. Characterization of fifty putative inclusion membrane proteins encoded in the Chlamydia trachomatis genome. Infect Immun 2008, 76(June (6)):2746-2757.
9. Zhong G., Fan P., Ji H., Dong F., Huang Y. Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors. J Exp Med 2001, 193(April (8)):935-942.
10. Zhong G., Lei L.S.G., Lu C., Qi M., Chen D. Chlamydia-secreted proteins in chlamydial interactions with host cells. Curr Chem Biol 2011, 5(1):9.
11. Valdivia R.H. Chlamydia effector proteins and new insights into chlamydial cellular microbiology. Curr Opin Microbiol 2008, 11(February (1)):53-59.
12. Betts-Hampikian H., Fields K. The chlamydial type III secretion mechanism: revealing cracks in a tough nut. Front Microbiol 2010, 1(October (1)):13.
13. Gong S., Lei L., Chang X., Belland R., Zhong G. Chlamydia trachomatis secretion of hypothetical protein CT622 into host cell cytoplasm via a secretion pathway that can be inhibited by the type III secretion system inhibitor compound 1. Microbiology 2011, 157(April (Pt4)):1134-1144.
14. Clifton D.R., Fields K.A., Grieshaber S.S., Dooley C.A., Fischer E.R., Mead D.J., et al. A chlamydial type III translocated protein is tyrosine-phosphorylated at the site of entry and associated with recruitment of actin. Proc Natl Acad Sci USA 2004, 101(July (27)):10166-10171.
15. Engel J. Tarp and Arp: how Chlamydia induces its own entry. Proc Natl Acad Sci USA 2004, 101(July (27)):9947-9948.
16. Hower S., Wolf K., Fields K.A. Evidence that CT694 is a novel Chlamydia trachomatis T3S substrate capable of functioning during invasion or early cycle development. Mol Microbiol 2009, 72(June (6)):1423-1437.
17. Sharma J., Bosnic A.M., Piper J.M., Zhong G. Human antibody responses to a Chlamydia-secreted protease factor. Infect Immun 2004, 72(December (12)):7164-7171.
18. Wang J., Zhang Y., Lu C., Lei L., Yu P., Zhong G. A genome-wide profiling of the humoral immune response to Chlamydia trachomatis infection reveals vaccine candidate antigens expressed in humans. J Immunol 2010, 185(August (3)):1670-1680.
19. Murphey C., Murthy A.K., Meier P.A., Neal-Guentzel M., Zhong G., Arulanandam BP The protective efficacy of chlamydial protease-like activity factor vaccination is dependent upon CD4+ T cells. Cell Immunol 2006, 242(August (2)):110-117.
20. Murthy A.K., Chambers J.P., Meier P.A., Zhong G., Arulanandam B.P. Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production. Infect Immun 2007, 75(February (2)):666-676.
21. Dhir S.P., Agarwal L.P., Gupta S.B., Detels R., Wang S.P., Grayston J.T. Trachoma vaccine trial in India: results of two-year follow-up. Indian J Med Res 1968, 56(August (8)):1289-1294.
22. Grayston J.T., Wang S.P., Woolridge R.L., Alexander E.R. Prevention of trachoma with vaccine. Arch Environ Health 1964, 8(April):518-526.
23. Morrison S.G., Su H., Caldwell H.D., Morrison R.P. Immunity to murine Chlamydia trachomatis genital tract reinfection involves B cells and CD4(+) T cells but not CD8(+) T cells. Infect Immun 2000, 68(December (12)):6979-6987.
24. Pal S., Peterson E.M., de la Maza L.M. Vaccination with the Chlamydia trachomatis major outer membrane protein can elicit an immune response as protective as that resulting from inoculation with live bacteria. Infect Immun 2005, 73(December (12)):8153-8160.
25. Zhong G., Berry J., Brunham R.C. Antibody recognition of a neutralization epitope on the major outer membrane protein of Chlamydia trachomatis. Infect Immun 1994, 62(May (5)):1576-1583.
26. Zhong G., Toth I., Reid R., Brunham R.C. Immunogenicity evaluation of a lipidic amino acid-based synthetic peptide vaccine for Chlamydia trachomatis. J Immunol 1993, 151(October (7)):3728-3736.
27. Su H., Messer R., Whitmire W., Hughes S., Caldwell H.D. Subclinical chlamydial infection of the female mouse genital tract generates a potent protective immune response: implications for development of live attenuated chlamydial vaccine strains. Infect Immun 2000, 68(January (1)):192-196.
28. Su H., Morrison R.P., Watkins N.G., Caldwell H.D. Identification and characterization of T helper cell epitopes of the major outer membrane protein of Chlamydia trachomatis. J Exp Med 1990, 172(July (1)):203-212.
29. Stephens R.S., Wagar E.A., Schoolnik G.K. High-resolution mapping of serovar-specific and common antigenic determinants of the major outer membrane protein of Chlamydia trachomatis. J Exp Med 1988, 167(March (3)):817-831.
30. Cotter T.W., Meng Q., Shen Z.L., Zhang Y.X., Su H., Caldwell H.D. Protective efficacy of major outer membrane protein-specific immunoglobulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital tract infection. Infect Immun 1995, 63(December (12)):4704-4714.
31. Perry L.L., Feilzer K., Hughes S., Caldwell H.D. Clearance of Chlamydia trachomatis from the murine genital mucosa does not require perforin-mediated cytolysis or Fas-mediated apoptosis. Infect Immun 1999, 67(March (3)):1379-1385.
32. Barteneva N., Theodor I., Peterson E.M., de la Maza L.M. Role of neutrophils in controlling early stages of a Chlamydia trachomatis infection. Infect Immun 1996, 64(November (11)):4830-4833.
33. Zhang D., Yang X., Lu H., Zhong G., Brunham R.C. Immunity to Chlamydia trachomatis mouse pneumonitis induced by vaccination with live organisms correlates with early granulocyte-macrophage colony-stimulating factor and interleukin-12 production and with dendritic cell-like maturation. Infect Immun 1999, 67(April (4)):1606-1613.
34. Lu H., Zhong G. Interleukin-12 production is required for chlamydial antigen-pulsed dendritic cells to induce protection against live Chlamydia trachomatis infection. Infect Immun 1999, 67(April (4)):1763-1769.
35. Murthy A.K., Sharma J., Coalson J.J., Zhong G., Arulanandam B.P. Chlamydia trachomatis pulmonary infection induces greater inflammatory pathology in immunoglobulin A deficient mice. Cell Immunol 2004, 230(July (1)):56-64.
36. Cheng W., Shivshankar P., Li Z., Chen L., Yeh I.T., Zhong G. Caspase-1 contributes to Chlamydia trachomatis-induced upper urogenital tract inflammatory pathologies without affecting the course of infection. Infect Immun 2008, 76(February (2)):515-522.
37. Shah A.A., Schripsema J.H., Imtiaz M.T., Sigar I.M., Kasimos J., Matos P.G., et al. Histopathologic changes related to fibrotic oviduct occlusion after genital tract infection of mice with Chlamydia muridarum. Sex Transm Dis 2005, 32(January (1)):49-56.
38. Patton D.L., Landers D.V., Schachter J. Experimental Chlamydia trachomatis salpingitis in mice: initial studies on the characterization of the leukocyte response to chlamydial infection. J Infect Dis 1989, 159(June (6)):1105-1110.
39. Morrison R.P., Caldwell H.D. Immunity to murine chlamydial genital infection. Infect Immun 2002, 70(June (6)):2741-2751.
40. Morrison S.G., Morrison R.P. A predominant role for antibody in acquired immunity to chlamydial genital tract reinfection. J Immunol 2005, 175(December (11)):7536-7542.
41. Fling S.P., Sutherland R.A., Steele L.N., Hess B., D'Orazio S.E., Maisonneuve J., et al. CD8+ T cells recognize an inclusion membrane-associated protein from the vacuolar pathogen Chlamydia trachomatis. Proc Natl Acad Sci USA 2001, 98(January (3)):1160-1165.
42. Lampe M.F., Wilson C.B., Bevan M.J., Starnbach M.N. Gamma interferon production by cytotoxic T lymphocytes is required for resolution of Chlamydia trachomatis infection. Infect Immun 1998, 66(November (11)):5457-5461.
43. Qi M., Lei L., Gong S., Liu Q., Delisa M., Zhong G. Chlamydia trachomatis secretion of an immunodominant hypothetical protein (CT795) into host cell cytoplasm. J Bacteriol 2011, 193(May (10)):2498-2509.
44. Rockey D.D., Heinzen R.A., Hackstadt T. Cloning and characterization of a Chlamydia psittaci gene coding for a protein localized in the inclusion membrane of infected cells. Mol Microbiol 1995, 15(February (4)):617-626.
45. Greene W., Xiao Y., Huang Y., McClarty G., Zhong G. Chlamydia-infected cells continue to undergo mitosis and resist induction of apoptosis. Infect Immun 2004, 72(January (1)):451-460.
46. Chu R.S., Targoni O.S., Krieg A.M., Lehmann P.V., Harding C.V. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J Exp Med 1997, 186(November (10)):1623-1631.
47. Zhang X., Gao L., Lei L., Zhong Y., Dube P., Berton M.T., et al. A MyD88-dependent early IL-17 production protects mice against airway infection with the obligate intracellular pathogen Chlamydia muridarum. J Immunol 2009, 183(July (2)):1291-1300.
48. Imtiaz M.T., Schripsema J.H., Sigar I.M., Kasimos J.N., Ramsey K.H. Inhibition of matrix metalloproteinases protects mice from ascending infection and chronic disease manifestations resulting from urogenital Chlamydia muridarum infection. Infect Immun 2006, 74(October (10)):5513-5521.
49. Xiao Y., Zhong Y., Su H., Zhou Z., Chiao P., Zhong G. NF-kappa B activation is not required for Chlamydia trachomatis inhibition of host epithelial cell apoptosis. J Immunol 2005, 174(February (3)):1701-1708.
50. Fan T., Lu H., Hu H., Shi L., McClarty G.A., Nance D.M., et al. Inhibition of apoptosis in chlamydia-infected cells: blockade of mitochondrial cytochrome c release and caspase activation. J Exp Med 1998, 187(February (4)):487-496.
51. Read T.D., Brunham R.C., Shen C., Gill S.R., Heidelberg J.F., White O., et al. Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39. Nucleic Acids Res 2000, 28(March (6)):1397-1406.
52. Sharma J., Zhong Y., Dong F., Piper J.M., Wang G., Zhong G. Profiling of human antibody responses to Chlamydia trachomatis urogenital tract infection using microplates arrayed with 156 chlamydial fusion proteins. Infect Immun 2006, 74(March (3)):1490-1499.
53. Cheng W., Shivshankar P., Zhong Y., Chen D., Li Z., Zhong G. Intracellular interleukin-1alpha mediates interleukin-8 production induced by Chlamydia trachomatis infection via a mechanism independent of type I interleukin-1 receptor. Infect Immun 2008, 76(March (3)):942-951.
54. Zhong G.M., Brunham R.C. Immunoaccessible peptide sequences of the major outer membrane protein from Chlamydia trachomatis serovar C. Infect Immun 1990, 58(October (10)):3438-3441.
55. Li Z., Chen D., Zhong Y., Wang S., Zhong G. The chlamydial plasmid-encoded protein pgp3 is secreted into the cytosol of Chlamydia-infected cells. Infect Immun 2008, 76(August (8)):3415-3428.
56. Chen L., Lei L., Chang X., Li Z., Lu C., Zhang X., et al. Mice deficient in MyD88 develop a Th2-dominant response and severe pathology in the upper genital tract following Chlamydia muridarum infection. J Immunol 2010, 184(March (5)):2602-2610.
57. Tang F.F., Huang Y.T., Chang H.L., Wong K.C. Isolation of trachoma virus in chick embryo. J Hyg Epidemiol Microbiol Immunol 1957, 1(2):109-120.
58. Wang Y. Etiology of trachoma: a great success in isolating and cultivating Chlamydia trachomatis. Chin Med J (Engl) 1999, 112(October (10)):938-941.
59. Clements C., Dhir S.P., Grayston J.T., Wang S.P. Long term follow-up study of a trachoma vaccine trial in villages of Northern India. Am J Ophthalmol 1979, 87(March (3)):350-353.
60. Wang S.P., Grayston J.T. A potency test for trachoma vaccine utilizing the mouse toxicity prevention test. Am J Ophthalmol 1967, 63(May (5, SUPPL.)):1443-1454.
61. Wang S.P., Grayston J.T., Alexander E.R. Trachoma vaccine studies in monkeys. Am J Ophthalmol 1967, 63(May (5, SUPPL.)):1615-1630.
62. Tammiruusu A., Penttila T., Lahesmaa R., Sarvas M., Puolakkainen M., Vuola J.M. Intranasal administration of chlamydial outer protein N (CopN) induces protection against pulmonary Chlamydia pneumoniae infection in a mouse model. Vaccine 2007, 25(January (2)):283-290.
63. Ishizaki M., Allen J.E., Beatty P.R., Stephens R.S. Immune specificity of murine T-cell lines to the major outer membrane protein of Chlamydia trachomatis. Infect Immun 1992, 60(September (9)):3714-3718.
64. Olsen A.W., Theisen M., Christensen D., Follmann F., Andersen P. Protection against Chlamydia promoted by a subunit vaccine (CTH1) compared with a primary intranasal infection in a mouse genital challenge model. PLoS ONE 2010, 5(5):e10768.
65. Pal S., Peterson E.M., de la Maza L.M. Intranasal immunization induces long-term protection in mice against a Chlamydia trachomatis genital challenge. Infect Immun 1996, 64(December (12)):5341-5348.
66. Cui Z.D., Tristram D., LaScolea L.J., Kwiatkowski T., Kopti S., Ogra P.L. Induction of antibody response to Chlamydia trachomatis in the genital tract by oral immunization. Infect Immun 1991, 59(April (4)):1465-1469.
67. Morrison R.P., Feilzer K., Tumas D.B. Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in Chlamydia trachomatis genital tract infection. Infect Immun 1995, 63(December (12)):4661-4668.
68. Marks E., Tam M.A., Lycke N.Y. The female lower genital tract is a privileged compartment with IL-10 producing dendritic cells and poor Th1 immunity following Chlamydia trachomatis infection. PLoS Pathog 2010, 6(11):e1001179.
69. Bai H., Cheng J., Gao X., Joyee A.G., Fan Y., Wang S., et al. IL-17/Th17 promotes type 1 T cell immunity against pulmonary intracellular bacterial infection through modulating dendritic cell function. J Immunol 2009, 183(November (9)):5886-5895.
70. Zhou X., Chen Q., Moore J., Kolls J.K., Halperin S., Wang J. Critical role of the interleukin-17/interleukin-17 receptor axis in regulating host susceptibility to respiratory infection with Chlamydia species. Infect Immun 2009, 77(November (11)):5059-5070.
71. Wuthrich M., Gern B., Hung C.Y., Ersland K., Rocco N., Pick-Jacobs J., et al. Vaccine-induced protection against 3 systemic mycoses endemic to North America requires Th17 cells in mice. J Clin Invest 2011, 121(Feb (2)):554-568.
72. Scurlock A.M., Frazer L.C., Andrews C.W., O'Connell C.M., Foote I.P., Bailey S.L., et al. IL-17 contributes to generation of Th1 immunity and neutrophil recruitment during Chlamydia muridarum genital tract infection but is not required for macrophage influx or normal resolution of infection. Infect Immun 2011, 79(Mar (3)):1349-1362.
73. Wu W., Li J., Chen F., Zhu H., Peng G., Chen Z. Circulating Th17 cells frequency is associated with the disease progression in HBV infected patients. J Gastroenterol Hepatol 2010, 25(April (4)):750-757.
74. De Nitto D., Sarra M., Cupi M.L., Pallone F., Monteleone G., Targeting IL-23 Th17-cytokines in inflammatory bowel diseases. Curr Pharm Des 2010, 16(33):3656-3660.
75. Guiton R., Vasseur V., Charron S., Arias M.T., Van Langendonck N., Buzoni-Gatel D., et al. Interleukin 17 receptor signaling is deleterious during Toxoplasma gondii infection in susceptible BL6 mice. J Infect Dis 2010, 202(August (3)):427-435.
76. Murthy A.K., Cong Y., Murphey C., Guentzel M.N., Forsthuber T.G., Zhong G., et al. Chlamydial protease-like activity factor induces protective immunity against genital chlamydial infection in transgenic mice that express the human HLA-DR4 allele. Infect Immun 2006, 74(December (12)):6722-6729.
77. Yu H., Karunakaran K.P., Kelly I., Shen C., Jiang X., Foster L.J., et al. Immunization with live and dead Chlamydia muridarum induces different levels of protective immunity in a murine genital tract model: correlation with MHC class II peptide presentation and multifunctional Th1 cells. J Immunol 2011, 186(March (6)):3615-3621.
78. Rey-Ladino J., Koochesfahani K.M., Zaharik M.L., Shen C., Brunham R.C. A live and inactivated Chlamydia trachomatis mouse pneumonitis strain induces the maturation of dendritic cells that are phenotypically and immunologically distinct. Infect Immun 2005, 73(March (3)):1568-1577.
79. Shaw J.H., Grund V.R., Durling L., Caldwell H.D. Expression of genes encoding Th1 cell-activating cytokines and lymphoid homing chemokines by chlamydia-pulsed dendritic cells correlates with protective immunizing efficacy. Infect Immun 2001, 69(July (7)):4667-4672.